SynAct Pharma Statements
SY
SynAct Pharma Income Statement
B
M
SEK (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
100
—
0
—
0
21.66
0
9.951
0
31.692
0
-31.692
0
-0.296
0
—
0
-31.988
0
-0.11
0
-31.878
0
-1.002
31.821
—
100
—
0
—
0
29.038
0
14.481
0
43.495
0
-43.495
0
-0.106
0
—
0
-43.601
0
-0.09
0
-43.511
0
-1.367
31.821
—
100
—
0
—
0
43.596
0
14.647
0
58.248
0
-58.248
0
0.102
0
—
0
-58.146
0
-8.268
0
-49.878
0
-1.592
31.338
—
100
—
0
—
0
21.663
0
8.987
0
30.523
0
-30.523
0
-0.031
0
-0.031
0
-30.554
0
-0.077
0
-30.477
0
-1.064
28.632
—
100
—
0
—
0
20.639
0
5.74
0
26.461
0
-26.461
0
-0.108
0
—
0
-26.569
0
-2.65
0
-23.919
0
-0.843
28.371
—
100
—
0
—
0
14.275
0
12.127
0
26.417
0
-26.417
0
-1.208
0
—
0
-27.625
0
-2.871
0
-24.754
0
-0.907
27.305
—
100
—
0
—
0
13.49
0
8.758
0
22.304
0
-22.304
0
-0.013
0
—
0
-22.317
0
-2.262
0
-20.055
0
-0.768
26.127
—
100
—
0
—
0
20.206
0
5.917
0
26.153
0
-26.153
0
-0.054
0
-0.001
0
-26.208
0
0.003
0
-26.21
0
-1.004
26.1
—
100
—
0
—
0
16.259
0
4.654
0
20.885
0
-20.885
0
0.209
0
—
0
-20.676
0
-2.454
0
-18.222
0
-0.697
26.127
—
100
—
0
—
0
12.952
0
2.686
0
15.603
0
-15.603
0
-0.253
0
—
0
-15.856
0
-2.719
0
-13.137
0
-0.503
26.127
—
100
—
0
—
0
11.073
0
2.967
0
14.058
0
-14.058
0
-0.011
0
—
0
-14.069
0
-2.335
0
-11.734
0
-0.46
25.484